Headquartered in Prague, Czech Republic, Neox is a CRO with over 150 employees who support biotechnology, pharmaceutical, and medical device customers. Neox has provided clinical research support for more than 1,000 studies and has built deep experience across multiple therapeutic areas. The company has operations primarily in central and eastern Europe, with a direct presence in the Czech Republic, Bulgaria, Germany, Hungary, Poland, Romania, Slovakia and Slovenia. Neox operates in another 11 European countries, including a recently established entity in the United Kingdom.
{iframe}https://www.privateequitywire.co.uk/2021/01/08/294134/behrman-capitals-emmes-acquires-neox{/iframe}